论文信息 - Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations - 字舞流文

Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations

S. Luen | A. Schram | M. Schwaederlé | S. Im | T. Yap | C. Pound | J. Balmaña | R. Baird | E. Lukács | S. Linardopoulos | Ganesha Moorthy | Jessica Brown | A. Sharp | Elizabeth A Pilling | S. Cosulich | Adam Dowson